J. L. Bainbridge & Co., Inc. Amgen Inc Transaction History

J. L. Bainbridge & Co., Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 28, 2021	SELL	$212.27 - $248.7 $192,316 - $225,322	-906 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $21,956 - $24,359	-94 Reduced 9.4%	906 $221,000
Q1 2021 May 12, 2021	SELL	$221.91 - $258.6 $15,533 - $18,102	-70 Reduced 6.54%	1,000 $249,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $19,945 - $22,180	85 Added 8.63%	1,070 $272,000
Q2 2020 Aug 11, 2020	SELL	$197.81 - $242.74 $8,505 - $10,437	-43 Reduced 4.18%	985 $232,000
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $10,752 - $14,260	-59 Reduced 5.43%	1,028 $208,000
Q2 2019 Jul 31, 2019	BUY	$166.7 - $195.41 $181,202 - $212,410	1,087 New	1,087 $200,000
Q1 2019 May 14, 2019	SELL	$180.87 - $203.88 $226,449 - $255,257	-1,252 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $231,983 - $261,530	1,252 New	1,252 $260,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of J. L. Bainbridge & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on J. L. Bainbridge & Co., Inc. with notifications on news.